Whitney Tilson Nails Big Short In UBIO, 3x levered Biotech ETF – ValueWalk Premium

Whitney Tilson Nails Big Short In UBIO, 3x levered Biotech ETF

Shorting is a tricky business. No fund manager is more aware of this than Whitney Tilson.

Nine times out of ten, Whitney Tilson is on the money when it comes to picking shorts (see below), but timing the shorts is a different game altogether.

A year ago (October 2014), as markets pushed to new highs Tilson made the decision to cover the majority of his short book. He covered 41 shorts and left eight open. Then, two months ago . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0